MétaCan
Menu
Back to cohort
Record W4388818400 · doi:10.14745/ccdr.v49i10a01

Summary of the National Advisory Committee on Immunization (NACI) Seasonal Influenza Vaccine Statement for 2023–2024

2023· article· en· W4388818400 on OpenAlexafffundvenue
Angela Sinilaité, Winnie Siu, Jesse Papenburg

Bibliographic record

VenueCanada Communicable Disease Report · 2023
Typearticle
Languageen
FieldMedicine
TopicInfluenza Virus Research Studies
Canadian institutionsMcGill UniversityMcGill University Health CentreMontreal Children's HospitalUniversity of OttawaPublic Health Agency of Canada
FundersHealth CanadaCenters for Disease Control and PreventionCanadian Armed ForcesAssociation des pharmaciens du CanadaAssociation of Medical Microbiology and Infectious Disease CanadaIndigenous Services CanadaPublic Health AgencyPublic Health Agency of Canada
KeywordsLive attenuated influenza vaccineMedicineVaccinationAdvisory committeeImmunizationInfluenza vaccineSeasonal influenzaContext (archaeology)ContraindicationFamily medicinePediatricsCoronavirus disease 2019 (COVID-19)ImmunologyPolitical scienceInternal medicineAlternative medicineDiseaseInfectious disease (medical specialty)GeographyPublic administrationImmune systemPathology

Abstract

fetched live from OpenAlex

Background: The National Advisory Committee on Immunization (NACI) reviews the evolving evidence on influenza immunization and provides annual recommendations regarding the use of seasonal influenza vaccines.The NACI Statement on Seasonal Influenza Vaccine for 2023-2024 updates the 2022-2023 NACI recommendations.Objective: To summarize the 2023-2024 NACI seasonal influenza vaccine recommendations and to highlight new and updated information.Methods: In the preparation of the Statement on Seasonal Influenza Vaccine for 2023-2024, the NACI Influenza Working Group applied the NACI evidence-based process to critically appraise the available evidence and to propose recommendations.The recommendations were then considered and approved by NACI in light of the available evidence.Results: Key changes for the 2023-2024 season include: 1) incorporation of updated information/guidance on influenza vaccination in the context of the coronavirus disease 2019 (COVID-19); 2) new recommendations for Flucelvax ® Quad and Influvac ® Tetra, the two quadrivalent inactivated influenza vaccines with expanded paediatric age indications; and 3) an update to the format of the Statement.Conclusion: Overall, NACI continues to recommend that an age-appropriate influenza vaccine should be offered annually to all individuals aged six months and older who do not have a contraindication to the vaccine, with particular focus on the groups for whom influenza vaccination is particularly recommended.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame machine prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.

metaresearch head score (Codex)0.012
metaresearch head score (Gemma)0.035
Version: metacan-v3-hybrid-931329e0061cValidation status: machine_predicted_unvalidated
Candidate categoriesnone
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Not applicable · Consensus signal: Not applicable
GenreCandidate signal: Editorial · Consensus signal: none
Teacher disagreement score0.989
Threshold uncertainty score0.717

Distilled classifier scores by category (both heads)

CategoryCodexGemma
Metaresearch0.0120.035
Meta-epidemiology (narrow)0.0010.001
Meta-epidemiology (broad)0.0010.001
Bibliometrics0.0030.002
Science and technology studies0.0010.001
Scholarly communication0.0020.001
Open science0.0030.001
Research integrity0.0030.005
Insufficient payload (model declined to judge)0.0230.013

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.088
GPT teacher head0.378
Teacher spread0.291 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.

The models applied no category: nothing in the taxonomy fit this work.
Study designNot applicable
Domainnot available
GenreEditorial

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations4
Published2023
Admission routes3
Has abstractyes

Explore more

Same venueCanada Communicable Disease ReportSame topicInfluenza Virus Research StudiesFrench-language works237,207